Gene flow and its sporadic spillover: H10 and N5 avian influenza viruses from wild birds and the H10N5 human cases in China

H5N1亚型流感病毒 病毒学 中国 生物 基因流 溢出效应 基因 禽流感病毒 遗传学 病毒 地理 遗传变异 经济 考古 微观经济学
作者
Weijie Chen,Shuiping Lu,Haiyan Xiong,Zhiyu Xiang,Yuxi Wang,Jingjing Hu,Yue Pan,Yanjiao Li,Qile Gao,Libin Chen,Siqi Hu,Weibing Wang,Chenglong Xiong
出处
期刊:Virologica Sinica [Springer Nature]
标识
DOI:10.1016/j.virs.2024.12.002
摘要

On January 30, 2024, China announced the first human case of H10N5 influenza infection. Prior to this, human cases of H10N7 and H10N8 had been reported. It is now appropriate to re-examine the evolution and future epidemiological trends of the H10 and N5 subtypes of avian influenza viruses (AIVs). In this study, we analyzed the reassortment characteristics of the first human-derived H10N5 AIV (A/Zhejiang/ZJU01/2023), as well as the evolutionary dynamics of the wild bird-derived H10 and N5 subtypes of AIVs over the past decade. Our findings indicate that the human-derived H10N5 AIV exhibited low pathogenicity. A/bean_goose/Korea/KNU-10/2022(H10N7) and A/mallard/Novosibirsk_region/962k/2018(H12N5) were identified as the potential reassortment parents. The virus has existed since 2022 and several isolations have been reported in Bangladesh. Phylogenetic analysis showed that H10Ny and HxN5 AIVs in China are clustered differently based on the East Asian-Australian (eastern) and Central Asian-Indian (western) migratory flyways. The H10Ny and HxN5 AIV reassortant strains may cause human infections through accidental spillover. It is possible that another center of AIV evolution, mutation, and reassortment may be developing along the migratory flyways in northeastern Asia, distinct from Europe, the Americas, and China's Yangtze River Delta and Pearl River Delta, which should be closely monitored to ensure the safety of the public.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
OCT发布了新的文献求助10
刚刚
冰兰阿托品完成签到,获得积分10
2秒前
cancan发布了新的文献求助10
2秒前
NINO完成签到,获得积分10
2秒前
2秒前
qawsed完成签到,获得积分10
2秒前
徐哈哈完成签到,获得积分10
3秒前
4秒前
4秒前
4秒前
4秒前
虞不见王完成签到 ,获得积分10
4秒前
香蕉觅云应助天马行空采纳,获得10
4秒前
颜如南发布了新的文献求助10
4秒前
小马甲应助简单小土豆采纳,获得10
6秒前
7秒前
吴晨曦发布了新的文献求助10
8秒前
judy发布了新的文献求助10
9秒前
张越完成签到,获得积分10
10秒前
荒年完成签到,获得积分10
10秒前
赘婿应助碧蓝的河马采纳,获得10
10秒前
Rex发布了新的文献求助10
10秒前
OCT完成签到,获得积分10
10秒前
12秒前
清脆的大娘完成签到,获得积分10
12秒前
xing完成签到,获得积分10
12秒前
科研通AI6.1应助LR123采纳,获得10
14秒前
14秒前
Sea_U应助谦让安白采纳,获得10
14秒前
15秒前
MSYzack发布了新的文献求助10
15秒前
Jeff完成签到,获得积分10
15秒前
16秒前
16秒前
奔跑西木发布了新的文献求助10
16秒前
17秒前
清图完成签到,获得积分10
17秒前
18秒前
19秒前
Forever发布了新的文献求助10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 2000
Research for Social Workers 1000
Psychology and Work Today 800
Mastering New Drug Applications: A Step-by-Step Guide (Mastering the FDA Approval Process Book 1) 800
Kinesiophobia : a new view of chronic pain behavior 600
Signals, Systems, and Signal Processing 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5896073
求助须知:如何正确求助?哪些是违规求助? 6708410
关于积分的说明 15732974
捐赠科研通 5018614
什么是DOI,文献DOI怎么找? 2702586
邀请新用户注册赠送积分活动 1649321
关于科研通互助平台的介绍 1598539